News

Media

Conferences

Publications

Clinical

Events

Resources

PBM Outcomes-Based Payment Model Launch Highlights AJPB Week in Review

September 25, 2016

Davy James, Managing Editor

Article

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos

selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com

$Video 9 - "Unmet Needs in Relapsed or Refractory Multiple Myeloma"$

Video 8 - "Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting"

Video 7 - "Role of Pharmacists in Operationalizing Bispecific Antibodies"

Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com

A panel of 3 experts on hepatic encephalopathy

A panel of 5 experts on ASCVD

A panel of 4 experts

Related Content

Research Finds In Utero Exposure to Ocrelizumab Not Associated With Increased Adverse Pregnancy, Infant Outcomes for Women With MS

Research Finds In Utero Exposure to Ocrelizumab Not Associated With Increased Adverse Pregnancy, Infant Outcomes for Women With MS

Aislinn Antrim, Assistant Managing Editor

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

breast cancer treatment/Image Credits: © ChenPG - adobe.stock.com

FDA Grants Inavolisib Priority Review for Treatment of PIK3CA-Mutated Breast Cancer

Alexandra Gerlach, Associate Editor

Public Health Matters: Getting Involved With State Pharmacy Associations, Advocating for Pharmacists, Promoting Professional Development

Public Health Matters: Getting Involved With State Pharmacy Associations, Advocating for Pharmacists, Promoting Professional Development

ESI Fees Violate Federal Policy; NCPA Pushes CMS for Clarity, Accountability

Women in labor receiving epidural -- Image credit: Firma V | stock.adobe.com

Receiving Epidural Analgesia During Labor May Reduce Serious Maternal Complications

Gillian McGovern, Assistant Editor

Related Content

Research Finds In Utero Exposure to Ocrelizumab Not Associated With Increased Adverse Pregnancy, Infant Outcomes for Women With MS

Research Finds In Utero Exposure to Ocrelizumab Not Associated With Increased Adverse Pregnancy, Infant Outcomes for Women With MS

Aislinn Antrim, Assistant Managing Editor

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

breast cancer treatment/Image Credits: © ChenPG - adobe.stock.com

FDA Grants Inavolisib Priority Review for Treatment of PIK3CA-Mutated Breast Cancer

Alexandra Gerlach, Associate Editor

Public Health Matters: Getting Involved With State Pharmacy Associations, Advocating for Pharmacists, Promoting Professional Development

Public Health Matters: Getting Involved With State Pharmacy Associations, Advocating for Pharmacists, Promoting Professional Development

ESI Fees Violate Federal Policy; NCPA Pushes CMS for Clarity, Accountability

Women in labor receiving epidural -- Image credit: Firma V | stock.adobe.com

Receiving Epidural Analgesia During Labor May Reduce Serious Maternal Complications

Gillian McGovern, Assistant Editor

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.